Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/RES.0000000000000718 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: Deregulation of mTORC1-TFEB axis in human iPSC model of -associated Parkinson's disease.
Front Neurosci
August 2025
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.
[This corrects the article DOI: 10.3389/fnins.2023.
View Article and Find Full Text PDFAberrant lysosomal dynamics disrupt myogenesis via mTORC1 signalling in X-linked myotubular myopathy.
Brain
July 2025
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
X-linked myotubular myopathy is a severe congenital muscle disorder caused by pathogenic variants in the MTM1 gene, which encodes the phosphoinositide phosphatase myotubularin. Muscle biopsies from patients with X-linked myotubular myopathy exhibit distinctive histopathological features, including small, rounded myofibres with centrally located nuclei, indicating a developmental defect in muscle maturation. While earlier studies have indicated that myotubularin dysfunction causes dysregulation of mechanistic target of rapamycin complex 1 (mTORC1) signalling, the underlying mechanisms and phenotypic impact on human muscle cells remain poorly understood.
View Article and Find Full Text PDFCorrection: Targeting tumour re-wiring by triple blockade of mTORC1, epidermal growth factor, and oestrogen receptor signalling pathways in endocrine-resistant breast cancer.
Breast Cancer Res
June 2025
The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, SW7 3RP, UK.
Psychedelics, entactogens and psychoplastogens for depression and related disorders.
Br J Pharmacol
June 2025
Department of Biochemistry and Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N-dimethyltryptamine, ayahuasca; non-hallucinogenic entactogens, e.
View Article and Find Full Text PDF